Brain & Spine Tumor Center at Northwestern Medicine Central DuPage Hospital and Northwestern Medicine Delnor Hospital
The Brain and Spine Tumor Center at Northwestern Medicine Central DuPage Hospital and Northwestern Medicine Delnor Hospital provides state-of-the-art tumor treatment, resources and support for patients and families to meet the challenges of living with a brain tumor.
Center Leadership and Team Approach
Under the leadership of Sean Grimm, MD, Osaama Khan, MD and a radiation oncologist that specializes in Central Nervous System (CNS) tumors, the care team of the Brain and Spine Tumor Center provides specialized experience and expertise in the treatment of brain and spine tumors. This team approach to care offers patients faster multi-disciplinary collaboration which results in optimal patient care. Dr. Grimm and Dr. Khan are members of the Lou and Jean Malnati Brain Tumor Institute (MBTI) and work jointly with the Robert H. Lurie Comprehensive Cancer Center of Northwestern University to provide advanced clinical trial research opportunities.
Sean Grimm, MD
Medical Director, Neuro-Oncology
Brain and Spine Tumor Center at Northwestern Medicine Central DuPage Hospital and Northwestern Medicine Delnor Hospital
Dr. Grimm is a fellowship-trained neuro-oncologist who practices in the Western Chicago Suburbs at the Northwestern Medicine Cancer Center Warrenville and Northwestern Medicine Cancer Center Delnor, and downtown Chicago at the Galter Pavilion on the Northwestern Memorial Hospital campus. After completing a fellowship in neuro-oncology at Memorial Sloan-Kettering Cancer Center in New York, he spent five years on the faculty at Northwestern University Feinberg School of Medicine prior to coming to Northwestern Medicine Central DuPage Hospital in 2013. Dr. Grimm specializes in the medical treatment of primary brain tumors (glioblastoma, anaplastic astrocytoma, oligodendroglioma, primary central nervous system [CNS] lymphoma,meningioma, and medulloblastoma), metastatic CNS tumors (brain metastases, spine metastases and leptomeningeal metastases), and the neurologic complications of cancer and its treatment (seizures, peripheral neuropathy, paraneoplastic disorders and general neurology).
He also designs and conducts clinical trials for patients with primary brain tumors.
Osaama H. Khan, MD, MSc
Director, Surgical Neuro-Oncology
Brain and Spine Tumor Center at Northwestern Medicine Central DuPage Hospital
Dr. Khan is the only fellowship-trained brain tumor neurosurgeon practicing and operating in the western Chicago suburbs. After completing his neurosurgery training in Toronto, Dr. Khan completed an oncology and skull-base fellowship at the University of Miami. He has also completed multiple research fellowships in France as well as New York.
Dr. Khan focuses on treating complex brain tumors in areas of the brain controlling such things as speech, motor functions and senses. He performs awake craniotomies, endoscopic approaches for pituitary tumors and minimally invasive surgery. He also uses Gamma Knife surgery for tumors and vascular lesions.
Completing the Brain and Spine Tumor Center leadership team is a dedicated radiation oncologist who specializes in the treatment of central nervous system tumors with proton beam therapy, Gamma Knife radiosurgery, intensity modulated radiotherapy and stereotactic radiosurgery.
Dedicated Team with Specialized Expertise
Given the complexity of treating brain tumors, being cared for by a multidisciplinary team of specialists, including neurosurgeons, neuro-oncologists, radiation oncologists, neuro-radiologists, pathologists, neuropsychologists and is optimal for achieving the best possible outcome.
The Brain and Spine Tumor Center at Northwestern Medicine Central DuPage Hospital and Northwestern Medicine Delnor Hospital offers easy access to brain tumor treatment and clinical trials close to a patient’s home.
Access to these specialists means that patients living in the western suburbs do not have to travel far from home for excellent care. Patients are seen at both the Northwestern Medicine Cancer Center Warrenville and Northwestern Medicine Cancer Center Delnor. Both cancer centers provide complimentary valet parking.
Brain and Spine Tumor Diagnoses
Our specialists are experts in the treatment of primary brain and spine tumors, secondary brain and spine tumors, and the neurologic complications of cancer and its treatment. A sample of diagnoses might include these:
- Primary brain tumor – glioblastoma, anaplastic astrocytoma, anaplastic oligodendroglioma, anaplastic ependymoma, astrocytoma, oligodendroglioma, ependymoma, medulloblastoma, pineoblastoma, primary CNS lymphoma, ganglioglioma, pituitary tumors, and meningioma
- Secondary brain and spine tumors – brain, spine and leptomeningeal metastases
- Neurologic complications of cancer – paraneoplastic disorders and general neurologic problems in patients with cancer
Comprehensive Program Featuring Advanced Technology
At the Brain and Spine Tumor Center at Northwestern Medicine Central DuPage Hospital and Northwestern Medicine Delnor Hospital, you have access to the latest technological advancements to treat brain tumors, delivered through a comprehensive program that includes:
- Weekly brain and spine tumor conference – (Mondays, 7:00-8:00 am at Northwestern Medicine Central DuPage Hospital and teleconferenced to the Northwestern Medicine Cancer Center Delnor, Northwestern Medicine Warrenville Cancer Center, Northwestern Medicine Kishwaukee Hospital and Northwestern Medicine Proton Center) and Fridays, 9:00-10:30 am at Northwestern Memorial Hospital. To submit a case, or for additional questions, please contact the Neuro-Oncology nurse navigator, Beth Bosshart-Frigo 630.352.5450 (TTY for the hearing impaired 630.933.4833).
- Weekly brain and spine tumor clinic and weekly brain metastases clinic – Patients and family members can visit with a neurosurgeon, neuro-oncologist, CNS-dedicated radiation oncologist, neuropsychologist, social worker, financial counselor, nutritionist, and occupational therapist in one visit.
- Clinical trial options – These are available for patients with glioblastoma, anaplastic astrocytoma, anaplastic oligodendroglioma, primary CNS lymphoma, and CNS metastases.
- Intraoperative MRI (iMRI) – Northwestern Medicine Central DuPage Hospital (CDH) is the only hospital in Illinois to offer full-field intraoperative MRI (i-MRI), a state-of-the-art surgical technology that provides high-quality, more detailed imaging viewable during surgery. By integrating this technology with advanced surgical techniques, your neurosurgeon can conduct scans during surgery to more safely and precisely remove brain tumors, especially around sensitive areas of the brain. This ensures maximum possible tumor removal, and minimizes the removal of healthy tissue.
- Advanced radiation therapy treatments – These include Stereotactic Radiosurgery (SRS), Tomotherapy®, and RapidArc®, advanced radiotherapy technologies that improve dose conformity, and may shorten treatment times.
- Proton therapy – One of the most precise forms of radiation therapy, proton treatment can be controlled so most of the radiation ends up directly in the tumor, reducing the risk of damage to surrounding healthy tissues, and causing fewer short- and long-term side effects. It has been effective in treating certain types of brain and spine cancer. Northwestern Medicine is the first and only health system in Illinois, and the ninth in the country, to offer proton therapy at the Northwestern Medicine Proton Center in Warrenville.1
- Gamma Knife® Radiosurgery - Gamma Knife® radiosurgery is an advanced cancer treatment used in multidisciplinary care plans at the Brain and Spine Tumor Center at Northwestern Medicine Cancer Care Center Warrenville. Gamma Knife is particularly well suited to treat brain tumors in difficult locations with less damage to surrounding healthy tissues. Benign, malignant, recurrent or metastatic brain tumors can all benefit from the precision of this safer treatment option.
- Brain Tumor resource and support groups – Patients and their families can find these groups at the Northwestern Medicine Cancer Center in Warrenville, LivingWell Cancer Resource Center in Geneva and Lou and Jean Malnati Brain Tumor Institute in Chicago.
- Endoscopic skull base surgery – Skull base surgery can be used to remove benign and cancerous tumors on the base of the brain or skull. This can be done using minimally invasive endoscopes to access these difficult-to-reach areas.
The Center offers a full complement of clinical trials for patients with brain tumors. A list of open brain tumor clinical trials is available here.
Learn more about the benefits and guidelines for participating in a clinical trial from the National Cancer Institute2.
Support Services for Brain and Spine Tumors
You have access to a wide range of support resources at the Brain and Spine Tumor Center at Northwestern Medicine Central DuPage Hospital and Northwestern Medicine Delnor Hospital, including a nutritionist, social worker and financial counselor.
LivingWell Cancer Resource Center, part of Northwestern Medicine, can be a vital component of your treatment and recovery. LivingWell serves as a gathering place, providing comfort and community to anyone experiencing the effects of cancer. The LivingWell staff works to ensure that you and your family feel less isolated, better informed, more hopeful and empowered to take on the challenge of facing cancer.
LivingWell services include more than 100 free-of-charge educational classes, support and networking groups, counseling, and classes in exercise, nutrition and stress reduction. The Brain Tumor Resource and Support Group meets at the following days/times:
- First and third Wednesdays of each month from 7:30 pm – 9:00 pm at LivingWell in Geneva
- Second Wednesday of the month from 6:00 pm – 7:30 pm at the Northwestern Medicine Cancer Center Warrenville
For more information or a schedule of events, contact the staff at email@example.com or 630.262.1111.
Make An Appointment
To find a brain tumor specialist, call 630.352.5450. TTY for hearing impaired 630.933.4833.